[144] National Vision Holdings, Inc. SEC Filing

Rhea-AI Filing Summary

National Vision Holdings insider transactions disclosed on a Form 144 show proposed and recent sales of common stock by an insider. The filing lists a proposed sale of 10,598 shares through Fidelity Brokerage, with an aggregate market value of $253,629.05, and an approximate sale date of 09/16/2025 on NASDAQ. The securities were acquired via a stock option exercise on 08/16/2021 and paid for in cash. The filing also reports two sales by Leonard R. Fahs on 08/28/2025 (137,400 shares, $3,343,335.27) and 09/15/2025 (2,002 shares, $47,670.10).

Positive

• Disclosure compliance: The Form 144 contains required details for the proposed sale and recent sales, including quantities, proceeds, and acquisition method.
• Acquisition origin: The shares proposed for sale were acquired via a stock option exercise, not newly issued shares, indicating insider did not receive new dilution at sale time.

Negative

• Large insider sales: Recent sales include 137,400 shares on 08/28/2025 for $3,343,335.27, which is material and could pressure the stock price.
• Additional proposed sale: A further 10,598 shares planned for 09/16/2025 may add supply and affect market perception of insider conviction.

Insights

Financial Analyst

TL;DR: Significant insider stock sales were recently executed and a further sale is proposed, which may influence market perception of EYE shares.

The filing documents substantive insider liquidity events: two recent sales by Leonard R. Fahs totaling 139,402 shares with gross proceeds of $3,390, ... (truncated in expert analysis to keep focused on materiality) and a proposed additional sale of 10,598 shares valued at $253,629.05. The shares to be sold were originally acquired via a stock option exercise on 08/16/2021 and paid in cash, indicating these are non-grant secondary dispositions rather than new issuances. From a financial viewpoint, the magnitude of the August 28 sale (over $3.34 million) is material relative to typical insider transactions and could affect short-term supply-demand dynamics for EYE stock. There is no forward guidance or earnings data in the filing to contextualize the sales.

Corporate Governance Expert

TL;DR: Multiple insider sales and a filed Form 144 show compliance with disclosure rules but raise standard governance questions about insider liquidity.

The Form 144 provides required disclosures and includes the seller's representation about lack of undisclosed material information. The shares proposed for sale were acquired by stock option exercise, and prior sales were reported with gross proceeds specified, demonstrating procedural compliance. From a governance perspective, the sequence of large sales by an insider warrants attention to trading plan details or blocking periods, but the filing itself contains no evidence of wrongdoing. The filing does not state adoption of a Rule 10b5-1 plan or indicate any trading plan dates.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10598	253629.05	79196383	09/16/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/16/2021	Stock Option Exercise	Issuer			10598	08/16/2021	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leonard R. Fahs 2435 Commerce Ave Building 2200 Duluth GA 30096	Common	08/28/2025	137400	3343335.27
Leonard R. Fahs 2435 Commerce Ave Building 2200 Duluth GA 30096	Common	09/15/2025	2002	47670.10

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales does the Form 144 for National Vision Holdings (EYE) report?

The filing reports a proposed sale of 10,598 shares (aggregate value $253,629.05) for sale on 09/16/2025, and two recent sales by Leonard R. Fahs: 137,400 shares on 08/28/2025 for $3,343,335.27 and 2,002 shares on 09/15/2025 for $47,670.10.

How were the shares being sold originally acquired?

The shares proposed for sale were acquired via a stock option exercise on 08/16/2021 and paid for in cash.

Through which broker are the proposed sales to be executed?

The proposed sale of 10,598 shares is to be executed through Fidelity Brokerage Services LLC on NASDAQ.

Does the filing state whether a Rule 10b5-1 trading plan was used?

The filing does not indicate adoption of a Rule 10b5-1 plan or provide any plan adoption date.

Who is the named seller in the recent transactions?

The recent sales are reported by Leonard R. Fahs with the address listed in Duluth, GA.